lampalizumab: Clinical Trials

5 trials of lampalizumab, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

4 terminated, 1 completed. 3 Phase 3, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	3	Terminated 3
Phase 2	2	Completed 1, Terminated 1

Follow lampalizumab: new trials by email Literature Review of lampalizumab trials Research Report on lampalizumab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) Lampalizumab - Geographic Atrophy	Phase 3	Terminated	Hoffmann-La Roche	994	2016-07-21	2019-03-06
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy Sham, Lampalizumab - Geographic Atrophy	Phase 2	Completed	Genentech, Inc.	96	2015-03-30	2019-09-25
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Lampalizumab, Sham Comparator - Geographic Atrophy	Phase 3	Terminated	Hoffmann-La Roche	975	2014-10-06	2019-10-15
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Lampalizumab, Sham - Geographic Atrophy	Phase 3	Terminated	Hoffmann-La Roche	906	2014-09-18	2019-06-26
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Lampalizumab - Geographic Atrophy	Phase 2	Terminated	Genentech, Inc.	159	2012-05-29	2019-09-11

Conditions studied

Sponsors

Countries

Results publications

NIH funding